Community Series in Novel Biomarkers for Predicting Response to Cancer Immunotherapy: Volume III

3,373
Total downloads
15k
Total views and downloads

Participate in this topic

Articles

SYSTEMATIC REVIEW

Published on 16 May 2025

Prognostic value of the systemic immune-inflammation index in non-small cell lung cancer patients treated with immune checkpoint inhibitors: a systematic review and meta-analysis

Guorong Chen
Bahu Bao
Yucai Ye
Aoyan Hu
Jingzi Sun
Weiying Liu

doi 10.3389/fonc.2025.1532343

341 views

ORIGINAL RESEARCH

Accepted on 13 May 2025

Serum IL-6 predicts immunotherapy-related adverse and outcome in advanced gastric and esophageal cancer patients with Anti-PD-1 treatment

Hongfang Ma
Shasha Zhang
Pengqing Jiao
Haixia Ding
Fujun Wang
Yue Zhao
Jianhua Wu
Zhanjun Guo

doi 10.3389/fimmu.2025.1553882

156 views

REVIEW

Published on 08 May 2025

Recent advances in biomarkers for predicting the efficacy of immunotherapy in non-small cell lung cancer

Jiacheng Zhang
Zehao Song
Yuanjie Zhang
Chentong Zhang
Qi Xue
Guochao Zhang
Fengwei Tan

doi 10.3389/fimmu.2025.1554871

531 views

ORIGINAL RESEARCH

Published on 08 May 2025

Toll-like receptor 3 activation enhances antitumor immune response in lung adenocarcinoma through NF-κB signaling pathway

Ang Li
Man Luo
Xiyao Liu
Hongjiao Wu
Xiaoguang Liu
Zhi Zhang
Xuemei Zhang

doi 10.3389/fimmu.2025.1585747

392 views

SYSTEMATIC REVIEW

Accepted on 02 May 2025

Role of tumor mutation burden in patients with urothelial carcinoma treated with immune checkpoint inhibitors: a systematic review and meta-analysis

Zhe Wang
Danxue Huang
Su Li
Liyuan Ke

doi 10.3389/fimmu.2025.1592761

ORIGINAL RESEARCH

Accepted on 28 Apr 2025

GPR65 is a novel immune biomarker and regulates the immune microenvironment in lung adenocarcinoma

Hanxu Zhou
Zhi Chen
Shuang Gao
Chaoqun Lian
Junjie Hu
Jin Lu
Lei Zhang

doi 10.3389/fimmu.2025.1572757

177 views

ORIGINAL RESEARCH

Published on 17 Apr 2025

BTG2-deficient mast cells remodel the tumor and tumor-draining lymph node microenvironment leading to chemotherapy resistance in breast cancer

Xiaoqian Zhang
Jiayi Wang
Ziyu Liu
Jiahuai Wen
Mengling Kang
Chen Fang
Liping Ren

doi 10.3389/fimmu.2025.1562700

1,023 views

ORIGINAL RESEARCH

Published on 04 Apr 2025

Development and validation of a disulfidptosis-related genes signature for predicting outcomes and immunotherapy in acute myeloid leukemia

Han Gong
Ying Zhang
Xusheng Wu
Yiming Pan
Mingwei Wang
Xiaofeng He
Jing Liu
Zhong Liu
Ling Li

doi 10.3389/fimmu.2025.1513040

1,091 views

REVIEW

Published on 24 Feb 2025

IFIT3: a crucial mediator in innate immunity and tumor progression with therapeutic implications

Rihan Wu
Hao Yang
Chunlei Liu

doi 10.3389/fimmu.2025.1515718

1,142 views

ORIGINAL RESEARCH

Published on 24 Feb 2025

Identification and functional characterization of T-cell exhaustion-associated lncRNA AL031775.1 in osteosarcoma: a novel therapeutic target

Yameng Wang
Jinghong Yuan
Keying Guo
Zhuoer Zhang
Junchao Zhu
Shahrzad Arya
Guowen Huang
Shengqin Li
Qi Chen
1 more
Jingyu Jia

doi 10.3389/fimmu.2025.1517971

1,113 views

ORIGINAL RESEARCH

Published on 17 Feb 2025

Multi-omics analysis identifies UBA family as potential pan-cancer biomarkers for tumor prognosis and immune microenvironment infiltration

Haibin Wang
XinLi Liu
Hesen Huang
Meng Tang
Jiwei Li
Tingting Huang
Shengjie Wang

doi 10.3389/fimmu.2025.1510503

1,080 views

ORIGINAL RESEARCH

Published on 27 Jan 2025

Unveiling immunogenic characteristics and neoantigens in endometrial cancer with POLE hotspot mutations for improved immunotherapy

Jian Huang
Shuangna Song
Yihua Yin
Yinyan He
Huimin Wang
Ye Gu
Laman He
Xintao Wang
Xiaocao Miao
2 more
Yiran Li

doi 10.3389/fimmu.2025.1528532

1,119 views

Share on

Frontiers in Immunology

Cancer Immunity and Immunotherapy

Participating Journals

Frontiers in Oncology
- Cancer Immunity and Immunotherapy
- 3.5 impact factor
- 6.2 citescore

Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.

Impact

15kTopic views
10kArticle views
3,373Article downloads

View impact

Articles

Prognostic value of the systemic immune-inflammation index in non-small cell lung cancer patients treated with immune checkpoint inhibitors: a systematic review and meta-analysis

Serum IL-6 predicts immunotherapy-related adverse and outcome in advanced gastric and esophageal cancer patients with Anti-PD-1 treatment

Recent advances in biomarkers for predicting the efficacy of immunotherapy in non-small cell lung cancer

Toll-like receptor 3 activation enhances antitumor immune response in lung adenocarcinoma through NF-κB signaling pathway

Role of tumor mutation burden in patients with urothelial carcinoma treated with immune checkpoint inhibitors: a systematic review and meta-analysis

GPR65 is a novel immune biomarker and regulates the immune microenvironment in lung adenocarcinoma

BTG2-deficient mast cells remodel the tumor and tumor-draining lymph node microenvironment leading to chemotherapy resistance in breast cancer

Development and validation of a disulfidptosis-related genes signature for predicting outcomes and immunotherapy in acute myeloid leukemia

IFIT3: a crucial mediator in innate immunity and tumor progression with therapeutic implications

Identification and functional characterization of T-cell exhaustion-associated lncRNA AL031775.1 in osteosarcoma: a novel therapeutic target

Multi-omics analysis identifies UBA family as potential pan-cancer biomarkers for tumor prognosis and immune microenvironment infiltration

Unveiling immunogenic characteristics and neoantigens in endometrial cancer with POLE hotspot mutations for improved immunotherapy

Frontiers in Immunology

Cancer Immunity and Immunotherapy

Participating Journals

Frontiers in Oncology

Cancer Immunity and Immunotherapy